TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003).

Luis Rivera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.